SSII
SS Innovations International, Inc.
There isn't enough reported data to score SSII yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
SSII Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
SSII's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SSII PE Valuation
SSII has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SSII Forward outlook
There aren't enough analyst estimates for SSII to show an outlook.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
SSII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.06 | $0.00 |
| Q1 2026 | -$0.05 | +$0.03 |
| Q4 2025 | -$0.06 | +$0.05 |
| Q3 2025 | -$0.06 | +$0.11 |
| Q2 2025 | -$0.06 | +$0.10 |
| Q1 2025 | -$0.08 | +$0.10 |
| Q4 2024 | -$0.11 | +$0.33 |
| Q3 2024 | -$0.17 | +$0.50 |
SSII is still losing money, but far less than before: $0.06 per share over the past year, against $1.60 at its worst in late 2019.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over SSII on earnings quality, reporting a profit while its opponent remains loss making.
SSII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $13.9M | +39% |
| Q1 2026 | $11.1M | +117% |
| Q4 2025 | $14.5M | +79% |
| Q3 2025 | $12.8M | +192% |
| Q2 2025 | $10M | +122% |
| Q1 2025 | $5.1M | +41% |
| Q3 2024 | $4.4M | +101% |
| Q2 2024 | $4.5M | +138% |
SSII has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -16% | -17 points |
| Q1 2026 | -33% | +83 points |
| Q4 2025 | -5.1% | +18 points |
| Q3 2025 | -14% | +59 points |
| Q2 2025 | 1% | +92 points |
| Q1 2025 | -116% | +155 points |
| Q4 2024 | -23% | N/A |
| Q3 2024 | -73% | +12 points |
SSII's operating margin was −16% last quarter, down 17 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over SSII on profitability, with a higher operating margin.
SSII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.2M | -$465.5K |
| Q1 2026 | -$2.4M | +$4.6M |
| Q4 2025 | -$3.2M | +$152.8K |
| Q3 2025 | -$8.2M | -$7.4M |
| Q2 2025 | -$3.8M | -$634.5K |
| Q1 2025 | -$7M | -$4.2M |
| Q4 2024 | -$3.4M | +$2.4M |
| Q3 2024 | -$844K | +$4.3M |
SSII has burned cash in almost every quarter: −$18M over the past year, against −$15M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over SSII on cash generation, producing positive trailing cash flow while its opponent burns cash.
SSII Net Leverage
SSII's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SSII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 21.7 | Oversold |
| Stochastic | 9.7 | Oversold |
SSII's weekly RSI is 22 (oversold) and its Stochastic is 10 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SSII PE vs Healthcare Sector
SSII has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SSII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.35 | 44% below |
| 20 week MA | $3.11 | 58% below |
| 50 week MA | $4.01 | 67% below |
| 100 week MA | $5.87 | 78% below |
UNH has stronger trend alignment. SSII is above 0 of 4 weekly averages versus UNH above 4 of 5.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
SSII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $3.75 | $8.00 | +113% |
| 2025 | $8.00 | $5.74 | -28% |
| 2026 YTD | $5.74 | $1.32 | -77% |
SSII has finished lower in one of the last two years. It's down 77% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over SSII on returns for 2026, with the stronger performance.